Alain Philippe Vasserot
Inventor
Stats
- 39 US patents issued
- 58 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 39 US Patents Issued
- 58 US Applications Filed
- 450 Total Citation Count
- Aug 7, 2023 Most Recent Filing
- Jan 21, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| a Tyr Pharma, Inc. | 3
| 2011
|
| GERON CORPORATION | 1
| 2008
|
| MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2
7 | 2015
2017 |
| UNITY BIOTECHNOLOGY, INC. | 1
2 7 | 2013
2015 2017 |
| ATYR PHARMA, INC. | 1
2 40 2 2 2 1 | 2009
2010 2011 2013 2014 2015 2016 |
| ELI LILLY AND COMPANY | 4
| 2006
|
| PANGU BIOPHARMA LIMITED | 41
2 | 2011
2015 |
| BUCK INSTITUTE FOR RESEARCH ON AGING | 1
2 7 | 2013
2015 2017 |
| Pangn Biopharma Limited | 1
| 2011
|
| THE JOHNS HOPKINS UNIVERSITY | 2
7 | 2015
2017 |
| APPLIED MOLECULAR EVOLUTION, INC. | 3
3 1 2 2 1 | 2004
2006 2009 2010 2011 2012 |
| ORTHO BIOTECH INC. | 2
2 2 3 | 2006
2009 2010 2011 |
| JANSSEN BIOTECH, INC. | 2
2 2 3 1 | 2006
2009 2010 2011 2012 |
| Kythera Biopharmaceuticals, Inc. | 1
| 2013
|
Inventor Addresses
| Address | Duration |
|---|---|
| 6421 La Paloma St. | Nov 16, 10 - Nov 16, 10 |
| CARLSBAD, CA, US | Apr 07, 11 - Feb 23, 12 |
| Carlsbad, CA | Jun 29, 06 - Nov 06, 08 |
| Carlsbad, CA, US | Jan 20, 09 - Dec 31, 19 |
| South San Francisco, CA, US | Apr 11, 24 - Apr 11, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 50 |
| A61M: | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY | 1 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 15 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0115,563 | 2024 | Treatment of a Senescence-Associated Ocular Disease or Disorder Using a Bcl-xL Selective Inhibitor | 0 |
| 10517866 | 2019 | Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor | 3 |
| 10478432 | 2019 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | 3 |
| 10478433 | 2019 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | 3 |
| 2019/0343,832 | 2019 | THERAPY FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED DISEASE USING AN MDM2 INHIBITOR | 4 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.